Centre Hospitalier de Saint-Brieuc   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Saint-Brieuc France (1433)

Organization Overview

First Clinical Trial
2009
NCT01233843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Centre Hospitalier de Saint-Brieuc | CH Brieuc | CH Saint Brieuc | CH St Brieuc | Clinique Armoricaine de Radiologie | Clinique Armoricaine de Radiologie, 22015 St Brieuc, France | Clinique Armoricaine de Radiologie - St Brieuc | Clinique Armoricaine SAINT BRIEUC France

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 3)

Adenocarcinoma (Phase 3)

Breast Neoplasms (Phase 2)

Head and Neck Neoplasms (Phase 2)

Prostatic Neoplasms (Phase 3)

Recurrence (Phase 3)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 7